Promising Cholesterol Drug Could Cut Heart Attack, Stroke Risk by Half

The new drug drastically cut LDL cholesterol levels and reduced the risk of heart attack and stroke.

Currently, statin therapy is the standard treatment for many patients with high cholesterol. But a new study published in The New England Journal of Medicine claims a drug called evolocumab could be much more effective; it reduced cholesterol levels so dramatically that patients’ risk of cardiovascular events — such as heart attack and stroke — fell by more than half, compared with those receiving standard therapy alone.

Lead study author Dr. Marc Sabatine, a senior physician at Brigham and Women’s Hospital in Boston, MA, and colleagues recently presented their findings at the American College of Cardiology’s 64th Annual Scientific Session in San Diego, CA.

READ FULL ARTICLE Curated publisher From Medical News Today